Correlates of Lymphedema in Women with Breast Cancer: a Case Control Study in Shiraz, Southern Iran |
Honarvar, Behnam
(Health Policy Research Center, Shiraz University of Medical Sciences)
Sayar, Negin (Health Policy Research Center, Shiraz University of Medical Sciences) Tahmasebi, Sedigheh (Lymphedema Clinic, Breast Diseases Research Center, Shiraz University of Medical Sciences) Zakeri, Zeinab (Lymphedema Clinic, Breast Diseases Research Center, Shiraz University of Medical Sciences) Talei, Asra (Lymphedema Clinic, Breast Diseases Research Center, Shiraz University of Medical Sciences) Rostami, Sara (Health Policy Research Center, Shiraz University of Medical Sciences) Khademi, Sahar (Health Policy Research Center, Shiraz University of Medical Sciences) Sarvestani, Amene Sabzi (Health Policy Research Center, Shiraz University of Medical Sciences) Sekhavati, Eghbal (Larestan School of Medical Sciences) |
1 | Afsharfard A, Mozaffar M, Orang E, et al (2013). Trends in epidemiology, clinical and histopathological characteristics of breast cancer in Iran: results of a 17 year study. Asian Pac J Cancer Prev, 14, 6905-11. DOI |
2 | Alcorso J, Sherman KA (2015). Factors associated with psychological distress in women with breast cancer-related lymphoedema. Psychooncology, 22, 1466-84. |
3 | Das N, Baumgartner RN, Riley EC, et al (2015). Treatment-related risk factors for arm lymphedema among long-term breast cancer survivors. J Cancer Surviv, 9, 422-30. DOI |
4 | Disipio T, Rye S, Newman B, et al (2013). Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol, 14, 500-15. DOI |
5 | Fu MR (2014). Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management. World J Clin Oncol, 5, 241-7. DOI |
6 | Golshan M, Smith B (2006). Prevention and management of arm lymphedema in the patient with breast cancer. J Support Oncol, 4, 381-6. |
7 | Haghighat S, Akbari ME, Ghaffari S, et al (2012). Standardized breast cancer mortality rate compared to the general female population of Iran. Asian Pac J Cancer Prev, 13, 5525-8. DOI |
8 | Honarvar B, Lankarani KB, Rostami S, et al (2015). Knowledge and practice of people toward their rights in urban family physician program: a population-based study in Shiraz, Southern Iran. Int J Prev Med, 4, 46. |
9 | Iuchi T, Dai M, Sanada H, et al (2015).Associations between the treatments and outcomes of patients with upper and lower lymphoedema in Japan: a cross-sectional observational study. Int J Nurs Stud, 52, 913-9. DOI |
10 | Jassim GA, Whitford Dl , Hickey A,Carter B, et al (2015). Psychological interventions for women with non-metastatic breast cancer. Cochrane Database Syst Rev, 28, 5. |
11 | Lankarani KB, Khosravizadegan Z,Rezaianzadeh A, Honarvar B, et al (2013). Data coverage of a cancer registry in southern Iran before and after implementation of a population-based reporting system: a 10-year trend study. BMC Health Serv Res, 6, 169. |
12 | Michael S, Charikleia S, Konstantinos K (2011). Lymphedema and breast cancer: A review of the literature. Br J Cancer, 18, 174-80. DOI |
13 | McNeely ML, Magee DJ , Lees AW, Bagnall KM, et al (2004). The addition of manual lymph drainage to compression therapy for breast cancer related lymphedema: a randomized controlled trial. Breast Cancer Res Treat, 86, 95-106. DOI |
14 | Merchant SJ, Chen SL (2015). Prevention and management of lymphedema after breast cancer treatment. Breast J, 21, 276-84. DOI |
15 | Mete Civelek G, Aypak C, Turedi O (2015). Knowledge of primary care physicians about breast-cancer-related lymphedema: Turkish perspective. J Cancer Educ, 4, 217-20. |
16 | Naderimagham S, Alipour S, Djalalinia S, et al (2014). National and sub-national burden of breast cancer in Iran; 1990-2013. Arch Iran Med, 17, 794-9. |
17 | Sadjadi A, Nouraie M, Ghorbani A, et al (2009). Epidemiology of breast cancer in the Islamic Republic of Iran: first results from a population-based cancer registry. East. Mediterr. health j, 15, 1426-31. |
18 | Taghian NR, Miller CL, Jammallo LS, et al (2014). Lymphedema following breast cancer treatment and impact on quality of life: a review. Crit Rev Oncol Hematol, 92, 227-34. DOI |
19 | Voss RK, Cromwell KD, Chiang YJ, et al (2015). The long-term risk of upper-extremity lymphedema is two-fold higher in breast cancer patients than in melanoma patients. J Surg Oncol, 112, 834-40. DOI |
20 | Zhu YQ, Xie YH, Liu FH, et al (2014). Systemic analysis on risk factors for breast cancer related lymphedema. Asian Pac J Cancer Prev, 15, 6535-41. DOI |